Prostaglandin combinations in glaucoma therapy

Details Prostaglandin combinations in glaucoma therapy Prostaglandin combinations in glaucoma therapy

1994-12-01

1996-10-15

Henley, III, Raymond

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Ester doai

514573, 514913, A61K 31215, A61K 3119, A61K 31557

Patent

active

055654924

ABSTRACT:
Disclosed is the use of combinations of F and E series prostaglandins and their respective derivatives and analogues, as well as pharmaceutically acceptable salts and esters thereof in the treatment of glaucoma and ocular hypertension. Also disclosed are ophthalmic, pharmaceutical compositions comprising said combinations.

REFERENCES:
patent: 4029681 (1977-06-01), Smith
patent: 4288616 (1981-09-01), Sih
patent: 4599353 (1986-07-01), Bito
patent: 5173507 (1992-12-01), DeSantis et al.
The Merck Index, 10th Edition (1983) pp. 1134-1135.
Osol, A., et al. "Remington's Pharmaceutical Sciences", published 1980 by Mack Publishing Co. (PA.), see p. 431.

Affiliated with

Also associated with

Rating

Prostaglandin combinations in glaucoma therapy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Prostaglandin combinations in glaucoma therapy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin combinations in glaucoma therapy will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1246607